Article
Biologic and clinical significance of androgen receptor variants in castration resistant prostate cancer.
Endocrine-related cancer - 1 Aug 2014
Ware Kathryn E, Garcia-Blanco Mariano A, Armstrong Andrew J, Dehm Scott M
Abstract excerpt
As prostate cancer (PCa) progresses to the lethal castration resistant and metastatic form, genetic and epigenetic adaptation, clonal selection, and evolution of the tumor microenvironment contribute to the emergence of unique biological characteristics under the selective pressure of external stresses. These stresses include the therapies applied in the clinic or laboratory and the exposures of cancers to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
